Literature DB >> 33508256

The use of dried blood spots for characterizing children's exposure to organic environmental chemicals.

Dana Boyd Barr1, Kurunthachalam Kannan2, Yuxia Cui3, Lori Merrill4, Lauren M Petrick5, John D Meeker6, Timothy R Fennell7, Elaine M Faustman8.   

Abstract

Biomonitoring is a commonly used tool for exposure assessment of organic environmental chemicals with urine and blood samples being the most commonly used matrices. However, for children's studies, blood samples are often difficult to obtain. Dried blood spots (DBS) represent a potential matrix for blood collection in children that may be used for biomonitoring. DBS are typically collected at birth to screen for several congenital disorders and diseases; many of the states that are required to collect DBS archive these spots for years. If the archived DBS can be accessed by environmental health researchers, they potentially could be analyzed to retrospectively assess exposure in these children. Furthermore, DBS can be collected prospectively in the field from children ranging in age from newborn to school-aged with little concern from parents and minimal risk to the child. Here, we review studies that have evaluated the measurement of organic environmental toxicants in both archived and prospectively collected DBS, and where available, the validation procedures that have been performed to ensure these measurements are comparable to traditional biomonitoring measurements. Among studies thus far, the amount of validation has varied considerably with no studies systematically evaluating all parameters from field collection, shipping and storage contamination and stability to laboratory analysis feasibility. These validation studies are requisite to ensure reliability of the measurement and comparability to more traditional matrices. Thus, we offer some recommendations for validation studies and other considerations before DBS should be adopted as a routine matrix for biomonitoring.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biomonitoring; Children; Dried blood spots; Nonpersistent organic pollutants; Organic toxicants; Persistent organic pollutants

Mesh:

Substances:

Year:  2021        PMID: 33508256      PMCID: PMC7988293          DOI: 10.1016/j.envres.2021.110796

Source DB:  PubMed          Journal:  Environ Res        ISSN: 0013-9351            Impact factor:   6.498


  128 in total

1.  High-sensitivity enzyme immunoassay for C-reactive protein in dried blood spots.

Authors:  Thomas W McDade; James Burhop; James Dohnal
Journal:  Clin Chem       Date:  2004-03       Impact factor: 8.327

2.  Preliminary investigation of the use of dried-blood spots for the assessment of in utero exposure to environmental pollutants.

Authors:  V W Burse; M R DeGuzman; M P Korver; A R Najam; C C Williams; W H Hannon; B L Therrell
Journal:  Biochem Mol Med       Date:  1997-08

3.  The U.S. National Health and Nutrition Examination Survey and human exposure to environmental chemicals.

Authors:  Antonia M Calafat
Journal:  Int J Hyg Environ Health       Date:  2011-09-19       Impact factor: 5.840

4.  Quantification of multiple elements in dried blood spot samples.

Authors:  Lise Pedersen; Karen Andersen-Ranberg; Mads Hollergaard; Mads Nybo
Journal:  Clin Biochem       Date:  2017-01-22       Impact factor: 3.281

5.  Therapeutic drug monitoring of tacrolimus with the dried blood spot method.

Authors:  K Hoogtanders; J van der Heijden; M Christiaans; P Edelbroek; J P van Hooff; L M L Stolk
Journal:  J Pharm Biomed Anal       Date:  2006-12-20       Impact factor: 3.935

6.  Serum, plasma, and dried blood spot high-sensitivity C-reactive protein enzyme immunoassay for population research.

Authors:  Eleanor Brindle; Masako Fujita; Jane Shofer; Kathleen A O'Connor
Journal:  J Immunol Methods       Date:  2010-09-17       Impact factor: 2.303

7.  Whole exome and whole genome sequencing with dried blood spot DNA without whole genome amplification.

Authors:  Laia Bassaganyas; George Freedman; Dedeepya Vaka; Eunice Wan; Richard Lao; Flavia Chen; Mark Kvale; Robert J Currier; Jennifer M Puck; Pui-Yan Kwok
Journal:  Hum Mutat       Date:  2017-11-06       Impact factor: 4.878

8.  Comparison of dried blood spot to venous methods for hemoglobin A1c, glucose, total cholesterol, high-density lipoprotein cholesterol, and C-reactive protein.

Authors:  David A Lacher; Lewis E Berman; Te-Ching Chen; Kathryn S Porter
Journal:  Clin Chim Acta       Date:  2013-04-06       Impact factor: 3.786

9.  Temporal trends of polybrominated diphenyl ethers (PBDEs) in the blood of newborns from New York State during 1997 through 2011: analysis of dried blood spots from the newborn screening program.

Authors:  Wan-Li Ma; Sehun Yun; Erin M Bell; Charlotte M Druschel; Michele Caggana; Kenneth M Aldous; Germaine M Buck Louis; Kurunthachalam Kannan
Journal:  Environ Sci Technol       Date:  2013-06-26       Impact factor: 9.028

Review 10.  Diagnostic accuracy of serological diagnosis of hepatitis C and B using dried blood spot samples (DBS): two systematic reviews and meta-analyses.

Authors:  Berit Lange; Jennifer Cohn; Teri Roberts; Johannes Camp; Jeanne Chauffour; Nina Gummadi; Azumi Ishizaki; Anupriya Nagarathnam; Edouard Tuaillon; Philippe van de Perre; Christine Pichler; Philippa Easterbrook; Claudia M Denkinger
Journal:  BMC Infect Dis       Date:  2017-11-01       Impact factor: 3.090

View more
  2 in total

Review 1.  Multiomics to elucidate inflammatory bowel disease risk factors and pathways.

Authors:  Manasi Agrawal; Kristine H Allin; Francesca Petralia; Jean-Frederic Colombel; Tine Jess
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-03-17       Impact factor: 73.082

Review 2.  A state-of-the-science review and guide for measuring environmental exposure biomarkers in dried blood spots.

Authors:  Tyler A Jacobson; Jasdeep S Kler; Yeunook Bae; Jiexi Chen; Daniel T Ladror; Ramsunder Iyer; Denise A Nunes; Nathan D Montgomery; Joachim D Pleil; William E Funk
Journal:  J Expo Sci Environ Epidemiol       Date:  2022-08-13       Impact factor: 6.371

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.